A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

India is enhancing its surveillance protocols following an Ebola outbreak in the Democratic Republic of Congo and Uganda. One of two suspec...

Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public inv...

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

A rare hantavirus outbreak linked to a cruise ship has drawn global attention after multiple infections and three reported deaths prompted ...

Cyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...

Markets often climb despite worries. In 2020, markets rose before economic recovery. Now, in 2026, markets are recovering amid geopolitical...

The BA.3.2 COVID-19 subvariant, known as “Cicada,” is spreading across the United States, with cases reported in 25 states and over 20 coun...

Cicada Covid Variant Symptoms: A new COVID variant with 70-75 spike protein mutations has been detected. The new virus can potentially evad...

The government had, in April 2021, first exempted Covid-19 vaccines from 10 per cent customs duty. The exemption was extended several times...

The exemption from import duty would help keep low the cost of overseas vaccines that are being eyed to supplement domestically made shots ...

"The Central Government, on being satisfied that it is necessary in the public interest so to do, hereby exempts the goods of the descripti...

In response to a question on when the WHO approval for Covaxin is expected, the minister said the data required for approval was submitted ...

Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.